Cite
Ughi N, Del Gaudio F, Dicuonzo A, et al. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. Eur Rev Med Pharmacol Sci. 2021;25(24):7985-7996doi: 10.26355/eurrev_202112_27649.
Ughi, N., Del Gaudio, F., Dicuonzo, A., Orso, M., Micheloni, G., Puoti, M., Pani, A., Scaglione, F., Zoppini, L., Rossetti, C., Epis, O. M., Bellavia, G., Giroldi, S., Moreno, M., & Bosio, M. (2021). Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. European review for medical and pharmacological sciences, 25(24), 7985-7996. https://doi.org/10.26355/eurrev_202112_27649
Ughi, N, et al. "Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare." European review for medical and pharmacological sciences vol. 25,24 (2021): 7985-7996. doi: https://doi.org/10.26355/eurrev_202112_27649
Ughi N, Del Gaudio F, Dicuonzo A, Orso M, Micheloni G, Puoti M, Pani A, Scaglione F, Zoppini L, Rossetti C, Epis OM, Bellavia G, Giroldi S, Moreno M, Bosio M. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7985-7996. doi: 10.26355/eurrev_202112_27649. PMID: 34982462.
Copy
Download .nbib